InsiderDB
Sign inStart free trial

Rep. Gilbert Ray Cisneros, Jr. sold Sarepta Therapeutics (SRPT)

Rep. Gilbert Ray Cisneros, Jr. (D-CA-31) · $1K–$15K · traded Apr 14, 2025

Transaction
Sold
Amount
$1K–$15K
Owner
Not stated
Traded
Apr 14, 2025
Disclosed
May 6, 2025
Days to disclose
22
Asset type
Stock
As filed
Sarepta Therapeutics, Inc. - Common Stock
Industry
Biotechnology · Healthcare
Official filing ↗All of Cisneros's tradesAll Congress trades in SRPT

Other trades in this filing

All of Cisneros's trades →

Recent Congress trades in SRPT

Company context for SRPT

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. SRPTLobbying report·Lobbying disclosures

    SRPT: third_quarter 2026 lobbying report

    H.R. 9260 - LHHS Appropriations Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to Section 232

    Public: Oct 19, 2026, 4:58 PM EDTOriginal source ↗
  2. SRPTLobbying report·Lobbying disclosures

    SRPT: second_quarter 2026 lobbying report

    H.R. 9260 - LHHS Appropriations H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to supply chain Issues related to Section 232

    Public: Jul 20, 2026, 1:40 PM EDTOriginal source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.